Evaluating the REST Scoring Method (Radiological Evaluation Score for Bone Tumors) as a Novel Radiological Tool in Distinguishing Benign and Malignant Bone Tumors: Accuracy Study at a Tertiary Referral Hospital
Main Article Content
Abstract
Introduction: The misdiagnosis due to high mimicking of bone tumor malignancy and uneven access to advanced examinations in rural areas are yet several problems in bone tumor examinations. Not to mention, the high morbidity and mortality rates indicate obstacles to these cases. This study analyses the accuracy of X-rays processed using a new modality, Radiological Evaluation Score for Bone Tumors (REST) in primary bone tumor patients at Dr. Soetomo Regional Hospital Surabaya. Methods: This study was an analytical observational study that analyzed the correlation between each scoring criterion and its total score with histopathology (biopsy) results, calculated the cut-off value for benign and malignant type scoring, and diagnosis accuracy. The sample totaled 142 samples by a total sampling technique. Analysis calculation and variables were explained in the chapter. Discussion: Based upon the obtained p values, it showed that 1) there was no correlation between age, cortical erosion, and pathological fractures with histopathological results (p ≥ 0.05); 2) there were correlation between gender, characteristic, tumor content, lesion boundaries, transition zone, periosteal reaction, connective tissue mass, and the total scoring with histopathological results (p < 0.05); 3) the cut-off value was 3.5; 4) the diagnostic accuracy was 85.3%. The kappa value for interobserver reliability was 0.764. Conclusion: The correlation of REST scoring with the histopathology results has shown dominantly significant with considered good diagnostic accuracy. These results have demonstrated a promising future development for the utilization of X-ray as bone tumour diagnosis modality.
Downloads
Article Details
References
Lilienthal I, Herold N. Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies. International Journal of Molecular Sciences. 2020;21(18):6885. doi: 10.3390/ijms21186885
Moukengue B, Lallier M, Marchandet L, Baud’huin M, Verrecchia F, Ory B, et al. Origin and Therapies of Osteosarcoma. Cancers 2022. 2022;14(14):3503. DOI: 10.3390/cancers14143503
Koster R, Panagiotou OA, Wheeler WA, Karlins E, Gastier-Foster JM, Caminada de Toledo SR, et al. Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients. Int J Cancer. 2018;142(8):1594–601. DOI: 10.1002/ijc.31195
Peterman NJ, Yeo E, Kaptur B, Smith EJ, Christensen A, Huang E, et al. Analysis of Rural Disparities in Ultrasound Access. Cureus. 2022;14(5). doi: 10.7759/cureus.25425
Zhang L, Wang Y, Gu Y, Hou Y, Chen Z. The need for bone biopsies in the diagnosis of new bone lesions in patients with a known primary malignancy: A comparative review of 117 biopsy cases. J Bone Oncol. 2019;14 :100213. DOI: 10.1016/j.jbo.2018.100213
Balach T, Stacy GS, Peabody TD. The clinical evaluation of bone tumors. Radiol Clin North Am. 2011;49(6):1079–93. DOI: 10.1016/j.rcl.2011.07.001
Miller TT. Bone tumors and tumorlike conditions: analysis with conventional radiography. Radiology. 2008;246(3):662–74. DOI: 10.1148/radiol.2463061038
Ayerza MA, Muscolo DL, Aponte-Tinao LA, Farfalli G. Effect of erroneous surgical procedures on recurrence and survival rates for patients with osteosarcoma. Clin Orthop Relat Res. 2006;452:231–5. DOI: 10.1097/01.blo.0000229314.58878.88
Salunke AA, Nandy K, Puj K, Kamani M, Pathak S, Shah J, et al. A proposed “Radiological Evaluation Score for Bone Tumors” (REST): An objective system for assessment of a radiograph in patients with suspected bone tumor. Musculoskelet Surg. 2022;106(4):371–82. DOI:10.1007/s12306-021-00716-9
Costelloe CM, Madewell JE. Radiography in the Initial Diagnosis of Primary Bone Tumors. American Journal of Roentgenology. 2013;200(1):3–7. DOI: 10.2214/AJR.12.8488
O’Brien SF, Yi QL. How do I interpret a confidence interval? Transfusion (The Journal of AABB). 2016;56(7):1680–3. DOI: 10.1111/trf.13635
Gerber E, Said-Hartley Q, Gamieldien R, Hartley T, Candy S. Accuracy of plain radiographs in diagnosing biopsy-proven malignant bone lesions. SA J Radiol. 2019;23(1):1768. doi: 10.4102/sajr.v23i1.1768
Azad H, Ahmed A, Zafar I, Bhutta MR, Rabbani MA, KC HR. X-ray and MRI Correlation of Bone Tumors Using Histopathology As Gold Standard. Cureus. 2022;14(7): e27262. DOI: 10.7759/cureus.27262
Osborne RL. The Differential Radiologic Diagnosis of Bone Tumors. CA: A Cancer Journal for Clinicians. 1974;24(4):194–211. DOI: 10.3322/canjclin.24.4.194
Setiawati, Rosy, Widyoningroem, A., Handarini, T., Hayati, F., Basja, A.T., Surya, A.R.D., Putri, Jaya, M.G., Andriani, J., Tanadi, M.R., Kamal, I.H., 2021. Modified chest X-ray scoring system in evaluating severity of COVID-19 patient in dr. Soetomo general hospital Surabaya, Indonesia. Int J Gen Med 14, 2407–2412. https://doi.org/10.2147/IJGM.S310577
Novariyanto, B., Setiawati, R., Rahardjo, P., Mustokoweni, S., Guglielmi, G., 2021. Apparent Diffusion Coefficient and Time Intensity Curve Values from Dynamic Contrast Enhancement (DCE) MRI in Osteosarcoma Histopathological Subtypes. International Journal of Research Publications 79. https://doi.org/10.47119/ijrp100791620212001
Sbaraglia, M., Bellan, E., Dei Tos, A.P., 2020. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives. Pathologica 113, 70. https://doi.org/10.32074/1591-951X-213